Further, T2DM remains one of the most significant risk factors not only for the development of MASLD but also for the progression of liver fibrosis and the occurrence of liverrelated complications, including HCC (Hosseinkhan et al., 2025
Compounded medications are not FDA-approved and have not undergone the same safety and efficacy review as commercial products
Marathe CS, Rayner CK, Jones KL, Horowitz M
GLP-1 medications are designed to manage an individuals blood sugar levels, and ultimately treat health issues like diabetes and obesity
Consistent with the incretin-mediated delivery of the PPAR// agonist, the metabolic effects of GLP-1GIPLani were blunted in DIO mice with pharmacological or genetic inhibition of GLP-1R, GIPR or PPAR, and vanished in double-incretin receptor knockout (DIR-KO) mice
At 12mg weekly, 4mg per injection